The Analytical Reliability of the Oral Glucose Tolerance Test for the Diagnosis of Gestational Diabetes: An Observational, Retrospective Study in a Caucasian Population.
Oral Glucose Tolerance Test (OGTT)
analytical issues
diagnosis
gestational diabetes
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
23 Jan 2022
23 Jan 2022
Historique:
received:
17
11
2021
revised:
31
12
2021
accepted:
17
01
2022
entrez:
15
2
2022
pubmed:
16
2
2022
medline:
16
2
2022
Statut:
epublish
Résumé
The Oral Glucose Tolerance Test (OGTT) is currently the gold standard reference test for the diagnosis of gestational diabetes mellitus (GDM). Several critical issues related to analytical variables have challenged its reproducibility and accuracy. This study aimed to assess the analytical reliability of the OGTT for the diagnosis of GDM. A total of 1015 pregnant women underwent a 2 h 75 g OGTT between 24 and 28 weeks of gestation. As recommended by National Academy of Clinical Biochemistry, we considered the total maximum allowable error for glucose plasma measurement as <6.9%. Assuming the possibility of analytical errors within this range for each OGTT glucose plasma value, different scenarios of GDM occurrence were estimated. GDM prevalence with standard criteria was 12.2%, and no hypothetical scenarios have shown a comparable GDM prevalence. Considering all the three OGTT values estimated at the lowest or the highest allowed value according to total maximum allowable error, GDM prevalence significantly varied (4.5% and 25.3%, respectively). Our results indicate that the OGTT is not completely accurate for GDM diagnosis.
Identifiants
pubmed: 35160016
pii: jcm11030564
doi: 10.3390/jcm11030564
pmc: PMC8837109
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
N Engl J Med. 2009 Oct 1;361(14):1339-48
pubmed: 19797280
Am J Obstet Gynecol. 1991 Feb;164(2):564-8
pubmed: 1992702
Diabetologia. 2016 Jul;59(7):1385-1390
pubmed: 27165093
Diabetes Care. 2021 Jan;44(Suppl 1):S15-S33
pubmed: 33298413
Aust N Z J Obstet Gynaecol. 2003 Dec;43(6):429-32
pubmed: 14712945
Diabetes Care. 2011 Nov;34(11):2454-7
pubmed: 21926292
Eur J Endocrinol. 2013 Nov 22;170(1):87-93
pubmed: 24114434
Clin Chem. 2011 Jun;57(6):e1-e47
pubmed: 21617152
N Engl J Med. 2005 Jun 16;352(24):2477-86
pubmed: 15951574
J Nucl Med. 1995 Dec;36(12):2220-8
pubmed: 8523109
J Clin Med. 2020 Oct 27;9(11):
pubmed: 33121014
Acta Diabetol. 2018 Dec;55(12):1261-1273
pubmed: 30221320
Diabetes Care. 2010 Mar;33(3):676-82
pubmed: 20190296
Am J Obstet Gynecol. 1993 Oct;169(4):874-81
pubmed: 8238142
Diabetes Care. 1998 Aug;21 Suppl 2:B79-84
pubmed: 9704232
Diabetes Res Clin Pract. 2015 Sep;109(3):493-9
pubmed: 26164090
Diabetes Care. 1998 Aug;21 Suppl 2:B161-7
pubmed: 9704245
J Clin Med. 2021 Feb 09;10(4):
pubmed: 33572314
Curr Diab Rep. 2019 Dec 4;19(12):155
pubmed: 31802260
Biomed Res Int. 2017;2017:2746471
pubmed: 28497042
J Matern Fetal Neonatal Med. 2014 Sep;27(14):1445-8
pubmed: 24175881